Dow Up0.12% Nasdaq Up1.35%

Oramed Pharmaceuticals Inc. (ORMP)

-NasdaqCM
7.66 0.30(4.08%) Oct 20, 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMay 31, 2014Feb 28, 2014Nov 30, 2013Aug 31, 2013
Total Revenue -   -   -   -  
Cost of Revenue -   -   -   -  
Gross Profit -   -   -   -  
Operating Expenses
Research Development1,089  673  751  295  
Selling General and Administrative814  512  418  683  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (1,903) (1,186) (1,168) (978)
Income from Continuing Operations
Total Other Income/Expenses Net79  74  46  (43)
Earnings Before Interest And Taxes(1,824)(1,112)(1,122)(1,021)
Interest Expense4  3  2  (25)
Income Before Tax(1,828)(1,115)(1,124)(996)
Income Tax Expense -   -   -  (205)
Minority Interest -   -   -   -  
Net Income From Continuing Ops(1,828)(1,115)(1,124)(791)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (1,828) (1,115) (1,124) (791)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (1,828) (1,115) (1,124) (791)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.